Oaktree Capital Sells $57.8M of Indivior Stock, Reduces Stake to 7.0%
INDIVIOR PLC
Subscribe to track INDV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Oaktree Capital Sells $57.8M of Indivior Stock, Reduces Stake to 7.0%
Company: INDIVIOR PLC (INDV) Form: SCHEDULE 13D/A | Filed: 2025-11-13 Significance: High
Insider: Oaktree Capital Holdings, LLC Title: N/A | Relationship: 10% Owner
Transaction: • Type: Sale • Shares: 1,946,969 • Price: (Multiple sales, avg ~$29.67) • Value: $57,763,105 • Owned After: 8,745,084 (7.0% of company)
Key Insight: Oaktree Capital executed a series of sales totaling 1.56% of Indivior's outstanding shares, a highly significant disposition valued at 1.5% of the company's market cap.
Market Context: The sales occurred over a one-month period, reducing the major institutional holder's stake from over 8.5% to 7.0%.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: INDIVIOR PLC (INDV)
Executive Summary
- Trading Significance: High
- Key Takeaway: Major institutional investor Oaktree Capital Holdings sold nearly 2 million shares of Indivior PLC for approximately $57.8 million, reducing its beneficial ownership to 7.0%.
- Market Impact: This series of sales is highly significant, representing 1.5% of the company's market capitalization and 1.56% of its outstanding shares, which could signal profit-taking or a strategic shift by a major shareholder.
Company Information
| Field | Value |
|---|---|
| Company | INDIVIOR PLC |
| Ticker Symbol | INDV |
| CIK | 0001625297 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Oaktree Capital Holdings, LLC |
| CIK | 0001790787 |
| Title/Position | N/A |
| Relationship | 10% Owner |
Transaction Details
This Schedule 13D/A amendment reports a series of dispositions by Oaktree and its affiliated funds. The aggregate transaction details are summarized below.
| Field | Value |
|---|---|
| Form Type | SCHEDULE 13D/A |
| Transaction Date | 10/14/2025 - 11/13/2025 |
| Transaction Code | S (Sale) |
| Security Type | Ordinary Shares |
| Shares Involved | 1,946,969 |
| Price Per Share | Weighted average of ~$29.67 |
| Total Value | $57,763,105 |
| Shares Owned After | 8,745,084 |
| Ownership Type | Indirect |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $57,763,105 |
| % of Market Cap | 1.50% |
| Shares Transacted | 1,946,969 |
| % of Shares Outstanding | 1.56% |
| Post-Transaction Ownership | 8,745,084 shares (7.0% of outstanding) |
| Materiality Assessment | Highly Significant |
Impact Evaluation
- Market Cap Context: With a market capitalization of $3.86 billion, the $57.8 million sale is a material event, exceeding the 1% threshold for high significance.
- Ownership Concentration: Oaktree remains a substantial shareholder with a 7.0% stake, but this sale represents a notable reduction in their position. Prior to these sales, their holdings were approximately 10,692,053 shares (8.56%). This sale constitutes a disposition of roughly 18.2% of their prior holdings.
- Dilution Impact: Not applicable, as this is a secondary market sale and does not involve the issuance of new shares.
- Transaction Significance: The transaction's size, both in absolute dollar value and as a percentage of market cap and outstanding shares, classifies it as highly significant. Such a large block of sales from a sophisticated institutional investor often attracts market scrutiny.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: While a large sale from a major holder can be perceived negatively, it could also represent routine portfolio rebalancing or profit-taking after a run-up in price (prices ranged from ~$24 to ~$31 during the sale period). The market's reaction will depend on whether this is viewed as the beginning of a complete exit or a partial trim.
Volume & Sentiment
- Expected Volume Impact: The sales, particularly the 830,000-share block on 10/30/2025, would have contributed to higher-than-average trading volume on the transaction dates.
- Sentiment Indicator: Neutral to Bearish. The reduction in stake by a major, well-regarded investment firm is not a bullish signal. However, without further context on Oaktree's motives, it's a neutral data point until a trend of continued selling is established.
Investment Insights
Positive Market Indicators
- Oaktree Capital still maintains a significant 7.0% stake, indicating continued, albeit reduced, conviction in the company.
Risk Factors
- A large, sophisticated investor is reducing its position, which could signal a perceived peak in valuation or emerging risks.
- The series of sales could create downward pressure on the stock price if the market interprets it as a lack of confidence from the institutional holder.
Key Takeaways
- Significant Disposition: Oaktree Capital sold $57.8 million worth of INDV stock, a transaction that is material relative to the company's market cap and shares outstanding.
- Reduced Stake: The sales reduced Oaktree's beneficial ownership from over 8.5% to 7.0%, a notable decrease in their position.
- Profit-Taking: The sales occurred across a range of prices, with a significant portion sold after the stock price increased, suggesting potential profit-taking.
Additional Context
Transaction Notes
- Timing: The sales were spread over one month, from October 14 to November 13, 2025, across nine separate trading days.
- Special Circumstances: The filing aggregates sales from multiple funds managed by Oaktree, reflecting a coordinated reduction in exposure across the firm.
- Market Environment: The transactions occurred as the share price was appreciating, with later sales happening at higher prices than the initial ones.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
